| Dr Jennette Danelle Hansen, MD | |
|
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
| (913) 588-6670 | |
| Not Available |
| Full Name | Dr Jennette Danelle Hansen |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 11 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093159121 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
Manduka, the world's leader in high performance yoga gear, announced today the launch of the new MatWare Mat Sleeve—the latest addition to its ergonomically inspired MatWare line of yoga mat carriers. Designed for the yogi who likes to keep their yoga mat protected while on the go, the MatWare Mat Sleeve—like all Manduka products—is sleek, convenient, innovative and earth friendly.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
Fatal poisonings involving paracetamol (acetaminophen) fell after a law introduced in the UK restricted the number of tablets that could be sold across the counter.
The New York Times reports that the Obama administration has begun an effort to use these arguments as an opportunity to educate the public and build support for the overhaul. Meanwhile, the Los Angeles Times reports that one of the lead plaintiffs in a challenge to the law has gone bankrupt with outstanding medical bills, leading some to question whether this transforms her from a "symbol of proud independence into an example of exactly the problem the healthcare law was intended to address."
› Verified 3 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Manduka, the world's leader in high performance yoga gear, announced today the launch of the new MatWare Mat Sleeve—the latest addition to its ergonomically inspired MatWare line of yoga mat carriers. Designed for the yogi who likes to keep their yoga mat protected while on the go, the MatWare Mat Sleeve—like all Manduka products—is sleek, convenient, innovative and earth friendly.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
Fatal poisonings involving paracetamol (acetaminophen) fell after a law introduced in the UK restricted the number of tablets that could be sold across the counter.
The New York Times reports that the Obama administration has begun an effort to use these arguments as an opportunity to educate the public and build support for the overhaul. Meanwhile, the Los Angeles Times reports that one of the lead plaintiffs in a challenge to the law has gone bankrupt with outstanding medical bills, leading some to question whether this transforms her from a "symbol of proud independence into an example of exactly the problem the healthcare law was intended to address."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennette Danelle Hansen, MD 1900 Swift Ave Ste 203, North Kansas City, MO 64116-3400 Ph: (816) 691-1765 | Dr Jennette Danelle Hansen, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6670 |
News Archive
Manduka, the world's leader in high performance yoga gear, announced today the launch of the new MatWare Mat Sleeve—the latest addition to its ergonomically inspired MatWare line of yoga mat carriers. Designed for the yogi who likes to keep their yoga mat protected while on the go, the MatWare Mat Sleeve—like all Manduka products—is sleek, convenient, innovative and earth friendly.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated with a higher risk of death and end stage renal disease for both women and men. The findings were released online in advance of publication in BMJ.
Fatal poisonings involving paracetamol (acetaminophen) fell after a law introduced in the UK restricted the number of tablets that could be sold across the counter.
The New York Times reports that the Obama administration has begun an effort to use these arguments as an opportunity to educate the public and build support for the overhaul. Meanwhile, the Los Angeles Times reports that one of the lead plaintiffs in a challenge to the law has gone bankrupt with outstanding medical bills, leading some to question whether this transforms her from a "symbol of proud independence into an example of exactly the problem the healthcare law was intended to address."
› Verified 3 days ago
Lyna Rehan, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 1034, Kansas City, KS 66160 Phone: 913-588-3304 Fax: 913-588-3365 | |
Dr. Joel Kent Grigsby, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3315 | |
O. Layton Alldredge Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Kansas University Medical Ctr, 3901 Rainbow Blvd Ms 1034, Kansas City, KS 66160 Phone: 913-588-3304 | |
Timothy Sowder, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Kumc 3901 Rainbow Blvd Ms 1034, Kansas City, KS 66160 Phone: 913-588-3302 Fax: 913-588-3365 | |
Robert P Devine, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-3315 | |
Jennifer B Kenny, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mail Stop 1034, Kansas City, KS 66160 Phone: 913-588-3315 Fax: 913-588-3365 | |
Dr. Sarafina Kristine Kankam, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 |